CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
about
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitorsGerm line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence.Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinasesDifferential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesisMurine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?EZH2 is highly expressed in pituitary adenomas and associated with proliferationA GRFa2/Prop1/stem (GPS) cell niche in the pituitaryDistinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitorsLack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesisThe INK4 family of cell cycle inhibitors in cancerRegulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferationMenin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4cThe ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesisMolecular cloning and characterization of the human p19INK4dgene promoterAn essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stressAltered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryosp27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.Mechanisms for pituitary tumorigenesis: the plastic pituitary.Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis.Pituitary gland development and disease: from stem cell to hormone productionp19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferationA new functional classification of tumor-suppressing genes and its therapeutic implications.Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.Enhanced LH action in transgenic female mice expressing hCGbeta-subunit induces pituitary prolactinomas; the role of high progesterone levelsGenetic analysis of mammalian cyclin-dependent kinases and their inhibitors.Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.INK4d-deficient mice are fertile despite testicular atrophyCooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity.Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d)Genetically engineered mouse models of pituitary tumorsLoss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.The molecular balancing act of p16(INK4a) in cancer and aging.MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.Mouse models of endocrine tumours.The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiation
P2860
Q24337658-B9124EE6-EE3B-4872-BC55-1767F9E220E5Q24540051-F5FE0369-455B-4830-AB4D-EC1AF3EB82DCQ24649057-1B058D04-58CB-4119-AB18-8F670DAE12F4Q24675863-7FD191D6-E872-49D6-9680-917947DAF96EQ26828446-4560CC19-EBD5-4DAF-9222-527B363EAE24Q27305296-D1CEE564-12A9-4ED1-91E0-6A7A19B367B4Q27350395-EDF20EE3-48E4-4C99-9C85-584C0E3D4886Q28139752-D7E0128C-E696-4752-B474-84BD4E327C84Q28144751-B9CFC1C4-0398-48B6-A614-4D713FC65493Q28145080-06CF4DDB-A85C-4533-AF99-CA70DA8A4230Q28206102-10DC65E0-C1B7-4E8E-823F-7AEFDF2F2B01Q28349872-BC1B8A5F-4335-49B3-9B5D-F13E7A48E8A1Q28506197-397F76AA-87EA-4018-9CBC-E91614CE4094Q28587433-BF2F97A3-BD1A-4062-B5C5-60ACAA360BB0Q29300177-69D412D5-A581-455C-BC06-9DC7B33C0D24Q30824986-BB153241-93F0-4195-9716-534B82BD586FQ33297829-49B93155-4D8A-4FB8-B04C-9AA2E9790387Q33535200-E8DEB827-CF2F-4D01-AAC2-B09672D46C62Q33551291-C28FD524-60E3-42DC-9388-84C1774C5979Q33630319-6E4279E2-4450-4C8B-B276-23DE42AF8C73Q33637242-203824E6-A80F-42E6-BCB6-5EF6B710CA48Q33687947-637026E6-45C6-4A4D-A340-619451E73A94Q33743648-7FCB1843-7E7D-445B-B795-15E19BFFC337Q33843457-34D80CAE-605A-4E57-B0F2-03ED0C3CCB1CQ33853215-9F9573B8-F16C-4150-B65A-063E7E98174BQ33896823-729C1F47-BAA3-4395-BDAD-9206D9A4A479Q33925119-3AFD289E-8E78-4B9F-9EFD-FE4380A92D2DQ33959792-E0491EE6-A505-4A92-87F9-128B2894B2A8Q33961317-BC94EEAB-31DC-41C4-85A7-097682797B4DQ33962726-A4572DD4-C27C-4037-A26A-7D17A0C16B8BQ33965112-FA870FE7-A29F-4399-A1C2-A9F22AB30D66Q33968117-5B938ECF-66AC-44FE-BE87-7AB08C40D4A9Q33984418-5D979A44-7161-4F44-9181-7287D036365CQ34035639-2460FE1D-0C7E-4FDE-9582-59AC10E1AE2CQ34038585-D3881B6B-23BE-44F7-B857-1395A323EF58Q34054054-CBA43720-5E54-4182-ACC5-1F6C75967FA2Q34078091-6486FC28-C36E-42E6-A790-AC029DE59C36Q34129129-278DF127-C719-4406-B204-C06DAE022785Q34133633-03870DC4-9E0E-40F3-A379-576702F24458Q34256767-A39DFE79-9232-43B6-AF6F-5F01CB4DAACE
P2860
CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
CDK inhibitors p18(INK4c) and ...... press pituitary tumorigenesis.
@ast
CDK inhibitors p18(INK4c) and ...... press pituitary tumorigenesis.
@en
type
label
CDK inhibitors p18(INK4c) and ...... press pituitary tumorigenesis.
@ast
CDK inhibitors p18(INK4c) and ...... press pituitary tumorigenesis.
@en
prefLabel
CDK inhibitors p18(INK4c) and ...... press pituitary tumorigenesis.
@ast
CDK inhibitors p18(INK4c) and ...... press pituitary tumorigenesis.
@en
P2093
P2860
P356
P1433
P1476
CDK inhibitors p18(INK4c) and ...... press pituitary tumorigenesis.
@en
P2093
D S Franklin
G I Kovalev
R Schoonhoven
S Chen-Kiang
V L Godfrey
P2860
P304
P356
10.1101/GAD.12.18.2899
P577
1998-09-01T00:00:00Z